Myelodysplastic–myeloproliferative diseases
Group of diseases
| Myelodysplastic–myeloproliferative diseases | |
|---|---|
| [[File:|250px|alt=|]] | |
| Synonyms | N/A |
| Pronounce | N/A |
| Field | Hematology |
| Symptoms | Fatigue, anemia, splenomegaly, fever |
| Complications | Acute myeloid leukemia, bone marrow failure |
| Onset | |
| Duration | |
| Types | Chronic myelomonocytic leukemia, Atypical chronic myeloid leukemia, Juvenile myelomonocytic leukemia |
| Causes | |
| Risks | |
| Diagnosis | Blood test, bone marrow biopsy |
| Differential diagnosis | |
| Prevention | N/A |
| Treatment | Chemotherapy, stem cell transplant |
| Medication | |
| Prognosis | |
| Frequency | |
| Deaths | |
Myelodysplastic–myeloproliferative diseases (MDS/MPN) are a group of hematologic disorders characterized by features of both myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPN). These diseases are marked by the abnormal growth and development of blood cells in the bone marrow, leading to a combination of cytopenias and cytoses.
Classification
Myelodysplastic–myeloproliferative diseases are classified into several subtypes, including:
- Chronic myelomonocytic leukemia (CMML)
- Atypical chronic myeloid leukemia (aCML)
- Juvenile myelomonocytic leukemia (JMML)
- Myelodysplastic/myeloproliferative neoplasm, unclassifiable (MDS/MPN-U)
Symptoms
Common symptoms of MDS/MPN include:
Complications
Patients with MDS/MPN are at risk for developing:
Diagnosis
Diagnosis of MDS/MPN typically involves:
- Blood tests to evaluate blood cell counts and morphology
- Bone marrow biopsy to assess the cellularity and presence of dysplastic or proliferative features
Treatment
Treatment options for MDS/MPN may include:
Related Pages
- Hematology
- Myelodysplastic syndromes
- Myeloproliferative neoplasms
- Chronic myelomonocytic leukemia
- Atypical chronic myeloid leukemia
- Juvenile myelomonocytic leukemia
- Acute myeloid leukemia
- Bone marrow biopsy
This article is a hematology stub. You can help WikiMD by expanding it!
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD